Recalls & Warnings May 24, 2013 Maker of Neuropathic Pain Product Warned For Drug Claims, Misbranding On April 11, 2013, the FDA issued a warning letter to Realm Labs, LLC, following a review of the companys websites which found statements made about its NeuRemedy products to be drug claims
Highdose vitamin C infusions are sometimes used as adjunct therapy in cancer treatment or to combat infections, but they may become prooxidative at very high concentrations and should only be administered by qualified professionals
Research applications depend on maintaining peptide integrity throughout the process
Analysis of the GSTF8-L and GSTF8-S proteins demonstrated that GSTF8-L is solely targeted to plastids, whereas GSTF8-S is cytoplasmic (Thatcher et al., 2007)
New England Journal of Medicine, 370(22), 20632066
They do serve different goals